# Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis

> **NCT06979271** · — · RECRUITING · sponsor: **Zhejiang Provincial People's Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Telitacicept
- Treatment Compliance
- Rheumatoid Arthritis

## Interventions

- **DRUG:** Telitacicept Tofacitinib

## Key facts

- **NCT ID:** NCT06979271
- **Lead sponsor:** Zhejiang Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2027-04-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06979271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06979271, "Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06979271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*